422 related articles for article (PubMed ID: 26910068)
1. In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin.
Ghose R; Mallick P; Taneja G; Chu C; Moorthy B
Methods Mol Biol; 2016; 1395():55-68. PubMed ID: 26910068
[TBL] [Abstract][Full Text] [Related]
2. Lower expression of HNF4α and PGC1α might impair rifampicin-mediated CYP3A4 induction under conditions where PXR is overexpressed in human fetal liver cells.
Takezawa T; Matsunaga T; Aikawa K; Nakamura K; Ohmori S
Drug Metab Pharmacokinet; 2012; 27(4):430-8. PubMed ID: 22333269
[TBL] [Abstract][Full Text] [Related]
3. Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane x receptor and its target gene CYP3a in mouse liver.
Xu DX; Wei W; Sun MF; Wu CY; Wang JP; Wei LZ; Zhou CF
Free Radic Biol Med; 2004 Jul; 37(1):10-22. PubMed ID: 15183191
[TBL] [Abstract][Full Text] [Related]
4. Pregnane X receptor mediated-transcription regulation of CYP3A by glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid-induced injury.
Wang YG; Zhou JM; Ma ZC; Li H; Liang QD; Tan HL; Xiao CR; Zhang BL; Gao Y
Chem Biol Interact; 2012 Oct; 200(1):11-20. PubMed ID: 22982774
[TBL] [Abstract][Full Text] [Related]
5. U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells.
Smutny T; Bitman M; Urban M; Dubecka M; Vrzal R; Dvorak Z; Pavek P
Arch Toxicol; 2014 Dec; 88(12):2243-59. PubMed ID: 24819614
[TBL] [Abstract][Full Text] [Related]
6. Reversing effects of ginsenosides on LPS-induced hepatic CYP3A11/3A4 dysfunction through the pregnane X receptor.
Sun HY; Yan YJ; Li YH; Lv L
J Ethnopharmacol; 2019 Jan; 229():246-255. PubMed ID: 30342195
[TBL] [Abstract][Full Text] [Related]
7. Induction of cytochrome P450 3A by paclitaxel in mice: pivotal role of the nuclear xenobiotic receptor, pregnane X receptor.
Nallani SC; Goodwin B; Maglich JM; Buckley DJ; Buckley AR; Desai PB
Drug Metab Dispos; 2003 May; 31(5):681-4. PubMed ID: 12695359
[TBL] [Abstract][Full Text] [Related]
8. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.
Li T; Chiang JY
Drug Metab Dispos; 2006 May; 34(5):756-64. PubMed ID: 16455805
[TBL] [Abstract][Full Text] [Related]
9. Activation of the aryl hydrocarbon receptor decreases rifampicin-induced CYP3A4 expression in primary human hepatocytes and HepaRG.
Rasmussen MK; Daujat-Chavanieu M; Gerbal-Chaloin S
Toxicol Lett; 2017 Aug; 277():1-8. PubMed ID: 28571685
[TBL] [Abstract][Full Text] [Related]
10. Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application.
Nibourg GA; Huisman MT; van der Hoeven TV; van Gulik TM; Chamuleau RA; Hoekstra R
Liver Transpl; 2010 Sep; 16(9):1075-85. PubMed ID: 20818746
[TBL] [Abstract][Full Text] [Related]
11. Role of c-Jun-N-Terminal Kinase in Pregnane X Receptor-Mediated Induction of Human Cytochrome P4503A4 In Vitro.
Taneja G; Chu C; Maturu P; Moorthy B; Ghose R
Drug Metab Dispos; 2018 Apr; 46(4):397-404. PubMed ID: 29440179
[TBL] [Abstract][Full Text] [Related]
12. A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system.
Raucy J; Warfe L; Yueh MF; Allen SW
J Pharmacol Exp Ther; 2002 Oct; 303(1):412-23. PubMed ID: 12235278
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a stable human cell line, HPL-A3, for use in reporter gene assays of cytochrome P450 3A inducers.
Sekimoto M; Sano S; Hosaka T; Nemoto K; Degawa M
Biol Pharm Bull; 2012; 35(5):677-85. PubMed ID: 22687401
[TBL] [Abstract][Full Text] [Related]
14. Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig.
Nannelli A; Chirulli V; Longo V; Gervasi PG
Toxicology; 2008 Oct; 252(1-3):105-12. PubMed ID: 18786598
[TBL] [Abstract][Full Text] [Related]
15. CYP3A4 Induction in the Liver and Intestine of Pregnane X Receptor/CYP3A-Humanized Mice: Approaches by Mass Spectrometry Imaging and Portal Blood Analysis.
Kobayashi K; Kuze J; Abe S; Takehara S; Minegishi G; Igarashi K; Kitajima S; Kanno J; Yamamoto T; Oshimura M; Kazuki Y
Mol Pharmacol; 2019 Nov; 96(5):600-608. PubMed ID: 31455676
[TBL] [Abstract][Full Text] [Related]
16. Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes.
Nallani SC; Goodwin B; Buckley AR; Buckley DJ; Desai PB
Cancer Chemother Pharmacol; 2004 Sep; 54(3):219-29. PubMed ID: 15175893
[TBL] [Abstract][Full Text] [Related]
17. A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line.
Trubetskoy O; Marks B; Zielinski T; Yueh MF; Raucy J
AAPS J; 2005 Mar; 7(1):E6-13. PubMed ID: 16146350
[TBL] [Abstract][Full Text] [Related]
18. In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors.
Zhang W; Purchio A; Chen K; Burns SM; Contag CH; Contag PR
Biochem Pharmacol; 2003 Jun; 65(11):1889-96. PubMed ID: 12781341
[TBL] [Abstract][Full Text] [Related]
19. Interactions of pharmaceuticals and other xenobiotics on hepatic pregnane X receptor and cytochrome P450 3A signaling pathway in rainbow trout (Oncorhynchus mykiss).
Wassmur B; Gräns J; Kling P; Celander MC
Aquat Toxicol; 2010 Oct; 100(1):91-100. PubMed ID: 20719396
[TBL] [Abstract][Full Text] [Related]
20. Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells.
Liu CL; Lim YP; Hu ML
Mar Drugs; 2012 Jan; 10(1):242-257. PubMed ID: 22363234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]